These references apply to the article on BHT .

[1] Snipes W, Person S, Keith A, Cupp J. Butylated hydroxytoluene inactivates lipid-containing viruses. Science. 1975;188(4183):64-6.

[2] Brugh M Jr. Butylated hydroxytoluene protects chickens exposed to Newcastle disease virus. Science. 1977;197(4310):1291-2.

[3] Kim KS, Moon HM, Sapienza V, Carp RI, Pullarkat R. Inactivation of cytomegalovirus and Semliki Forest virus by butylated hydroxytoluene. J Infect Dis 1978;138(1):91-4.

[4] Pirtle EC, Sacks JM, Nachman RJ. Antiviral effectiveness of butylated hydroxytoluene against pseudorabies (Aujeszky's disease) virus in cell culture, mice, and swine. Am J Vet Res. 1986;47(9):1892-5.

[5] Richards JT, Katz ME, Kern ER. Topical butylated hydroxytoluene treatment of genital herpes simplex virus infections of guinea pigs. Antiviral Res 1985;5(5):281-90.

[6] Aloia RC, Jensen FC, Curtain CC, Mobley PW, Gordon LM. Lipid composition and fluidity of the human immunodeficiency virus. Proc Natl Acad Sci U S A 1988;85(3):900-4.

[7] Chetverikova LK, Ki'ldivatov II, Inozemtseva LI, Kramskaia TA, Filippov VK, Frolov BA. Factors of antiviral resistance in the pathogenesis of influenza in mice [in Russian]. Vestn Akad Med Nauk SSSR 1989;(11):63-8.

[8] Pearson D, Shaw S. Life Extension: A Practical Scientific Approach. New York, NY: Warner Books, Inc.; 1982:206-207.

[9] Mann JA, Fowkes SW. Wipe Out Herpes with BHT. Manhattan Beach, Calif: MegaHealth Society; 1983.

[10] Lanigan RS, Yamarik TA, Final report on the safety assessment of BHT, Int. J. Toxicol., 2002:21 Suppl 2:19-94

[11] Shlian DM, Goldstone J, Toxicity of butylated hydroxytoluene, N Engl J Med, 1986; 34; 648-649

[12] http://www.vrp.com/showdoc.asp?c=1161225336828&k=/vrpsearch.asp&m=/includes/vrp.css&p=no&s=0

[13 Williams GM, Iatropoulos MJ. Inhibition of the hepatocarcinogenicity of aflatoxin B1 in rats by low levels of the phenolic antioxidants butylated hydroxyanisole and butylated hydroxytoluene. Cancer Lett 1996;104(1):49-53.

[14] McKee RH, Tometsko AM. Inhibition of promutagen activation by the antioxidants butylated hydroxyanisole and butylated hydroxytoluene. J Natl Cancer Inst 1979;63(2):473-7.

[15] Franklin RA. Butylated hydroxytoluene in sarcoma-prone dogs. Lancet 1976;1(7972):1296.

[16] Schwarz KB. Oxidative stress during viral infection: a review. Free Radic Biol Med 1996;21(5):641-9.

[17] Hannuksela M, Lahti A. Peroral challenge tests with food additives in urticaria and atopic dermatitis. Int J Dermatol 1986;25(3):178-80.

Disclaimer: The information in this article and on this website is not intended to diagnose, treat, cure or prevent any disease. None of the products mentioned in this article or on this website are intended to diagnose, treat, cure or prevent any disease. The information in this article is not intended to provide personal medical advice, which should be obtained from a medical professional. This information is made available with the understanding that the author and publisher are not providing medical, psychological, or nutritional counseling services on this site. The information on this Web site does not cover all possible uses, actions, precautions, side effects, and interactions. Liability for individual actions or omissions based upon the contents of this site is expressly disclaimed. This information has not been evaluated or approved by the U.S. FDA.

|  Home |   Products |   Research Links |  Contact |   Privacy Policy |  



© copyright 2009 Clear Springs Press, LLC. All rights reserved.